Developing Global Cellular Information Retrieval System with Minimum Reporting Guidelines on Cellular Data for Regenerative Medicine

A wide range of stem cell research towards regenerative medicine has been conducted in a large number of domains in the world over the years. However, those produced data and information are not fully utilized and sometimes causes failure to be reproduced among laboratories or cell banks due to a lack of standardization of cellular assay reporting formats. To maximize a value placed on the information in stem cell and derivative cell research, we have proposed reporting guidelines for describing cellular assay data to pursue the facilitation of practical regenerative medicine named ‘Minimum Information About a Cellular Assay for Regenerative Medicine (MIACARM)’. MIACARM has been developed based on the existing Minimum Information About a Cellular Assay (MIACA) with defined taxonomy of human cell types, which allows for the description of advanced cellular experiments. MIACARM is applicable for exchanging data from not only for basic cellular assay, but also stem cell assay data that are produced and provided by cell banks, registries, or other academic institutions all over the world. And here we would like to introduce our recent progress that is developing stem cell data retrieval system based on MIACARM.